212 related articles for article (PubMed ID: 16477581)
1. Idiopathic myelofibrosis: pathogenesis to treatment.
Reilly JT
Hematol Oncol; 2006 Jun; 24(2):56-63. PubMed ID: 16477581
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic myelofibrosis.
Barosi G; Hoffman R
Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and management of idiopathic myelofibrosis.
Reilly JT
Baillieres Clin Haematol; 1998 Dec; 11(4):751-67. PubMed ID: 10640215
[TBL] [Abstract][Full Text] [Related]
4. Advances in the therapy of chronic idiopathic myelofibrosis.
Arana-Yi C; Quintás-Cardama A; Giles F; Thomas D; Carrasco-Yalan A; Cortes J; Kantarjian H; Verstovsek S
Oncologist; 2006 Sep; 11(8):929-43. PubMed ID: 16951397
[TBL] [Abstract][Full Text] [Related]
5. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
Tefferi A
Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation as treatment for myelofibrosis.
Papageorgiou SG; Castleton A; Bloor A; Kottaridis PD
Bone Marrow Transplant; 2006 Dec; 38(11):721-7. PubMed ID: 17013423
[TBL] [Abstract][Full Text] [Related]
7. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
8. New and old treatment modalities in primary myelofibrosis.
Cervantes F; Mesa R; Barosi G
Cancer J; 2007; 13(6):377-83. PubMed ID: 18032975
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
Chagraoui H; Wendling F; Vainchenker W
Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
[TBL] [Abstract][Full Text] [Related]
11. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
[TBL] [Abstract][Full Text] [Related]
12. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
Dupriez B; Demory JL
Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
[TBL] [Abstract][Full Text] [Related]
13. Primary myelofibrosis: update on definition, pathogenesis, and treatment.
Abdel-Wahab OI; Levine RL
Annu Rev Med; 2009; 60():233-45. PubMed ID: 18947294
[TBL] [Abstract][Full Text] [Related]
14. Modern management of myelofibrosis.
Cervantes F
Br J Haematol; 2005 Mar; 128(5):583-92. PubMed ID: 15725078
[TBL] [Abstract][Full Text] [Related]
15. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
Mesa RA
Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
[TBL] [Abstract][Full Text] [Related]
16. A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.
Poodt J; Fijnheer R; Walsh IB; Hermans MH
Hematol Oncol; 2006 Dec; 24(4):227-33. PubMed ID: 17006961
[TBL] [Abstract][Full Text] [Related]
17. New insights into the pathogenesis and drug treatment of myelofibrosis.
Tefferi A
Curr Opin Hematol; 2006 Mar; 13(2):87-92. PubMed ID: 16456374
[TBL] [Abstract][Full Text] [Related]
18. [Idiopathic myelofibrosis. Main pathogenetic, prognostic and therapeutic aspects].
Barulli S; Rupoli S; Cinciripini A; Scortechini AR; Cantori I; Leoni P
Recenti Prog Med; 1995; 86(7-8):312-9. PubMed ID: 7569290
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic myelofibrosis: pathogenesis, natural history and management.
Reilly JT
Blood Rev; 1997 Dec; 11(4):233-42. PubMed ID: 9481452
[TBL] [Abstract][Full Text] [Related]
20. Myelofibrosis--pathophysiology and treatment.
Cole DR; Pung J; Pung F; Cole DF
Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):68-70. PubMed ID: 370037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
